Αποτελέσματα Αναζήτησης
6 Ιουλ 2022 · During the 2022 session, the New York Assembly and Senate passed a copay accumulator ban bill that will ensure all cost-sharing by or on behalf of patients counts towards meeting their deductible and annual out-of-pocket limits (S5229A/A1741-A); and a bill that redefines the term “clinical peer reviewer” to ensure that health plans only use ...
- Federal
On September 20th, 2024, the Federal Trade Commission (FTC)...
- Multimedia
During the 2024 legislative session, Vermont passed a...
- Policymakers
On August 28, 2024, The AIDS Institute released an analysis...
- Federal
BILL NUMBER: S5299 SPONSOR: RIVERA TITLE OF BILL: An act to amend the insurance law, in relation to calculating an insured individual's overall contribution to any out-of-pocket maximum or any cost-sharing requirement PURPOSE OR GENERAL IDEA OF BILL: Requires insurance companies or pharmacy benefit managers to apply price reduction instruments ...
13 Δεκ 2023 · Governor Hochul today signed legislation to protect New York consumers from medicine price-gouging and ongoing financial consequences related to medical debt. Additionally, the Governor signed bills what will curb predatory subscription services, and confusion over the price of many goods and services.
22 Ιουν 2023 · Over the past several years, state legislators have passed bills aimed at banning the use of copay accumulator programs and ensuring that any third-party copay assistance used by a patient is counted toward the cost-sharing limits of that patient’s plan.
SUMMARY OF SPECIFIC PROVISIONS: Every New York resident will be eligible to enroll, regardless of age, income, wealth, employment, or other status. There would be no network restrictions, deductibles, or co-pays.
7 Σεπ 2022 · The governors of New York and Delaware have co-pay accumulator ban bills on their desks awaiting signature. And other states legislatures have signaled they will consider the issue in upcoming sessions.
12 Μαρ 2021 · This legislation, S.5299/A.1741, requires insurance companies or pharmacy benefit managers to apply price reduction instruments for out-of-pocket expenses when calculating an insured individual’s cost-sharing requirement, allowing consumers to apply drug coupons and discounts toward their annual out-of-pocket deductible costs.
